Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.

Eudy AM, Voora D, Myers RA, Clowse MEB.

Lupus. 2019 Nov 4:961203319886069. doi: 10.1177/0961203319886069. [Epub ahead of print]

PMID:
31684818
2.

Development of ReproKnow, a reproductive knowledge assessment for women with rheumatic diseases.

Birru Talabi M, Clowse MEB, Blalock SJ, Switzer G, Yu L, Chodoff A, Borrero S.

BMC Rheumatol. 2019 Oct 21;3:40. doi: 10.1186/s41927-019-0091-6. eCollection 2019.

3.

Pregnancy in Women With Lupus: We Have Come So Far and Have So Far to Go.

Clowse MEB.

Ann Intern Med. 2019 Aug 6;171(3):212-213. doi: 10.7326/M19-1667. Epub 2019 Jul 9. No abstract available.

PMID:
31284297
4.

Perspectives of Adult Rheumatologists Regarding Family Planning Counseling and Care: A Qualitative Study.

Birru Talabi M, Clowse MEB, Blalock SJ, Hamm M, Borrero S.

Arthritis Care Res (Hoboken). 2019 Mar 15. doi: 10.1002/acr.23872. [Epub ahead of print]

PMID:
30875455
5.

It Is Time to Modify Treatment to Enable More Women with Rheumatoid Arthritis to Have Successful Pregnancies.

Clowse MEB.

J Rheumatol. 2019 Mar;46(3):223-225. doi: 10.3899/jrheum.181036. No abstract available.

PMID:
30824666
6.

Contraception methods used by women with rheumatoid arthritis and psoriatic arthritis.

Leverenz DL, Eudy AM, Jayasundara M, Haroun T, McDaniel G, Benjamin Nowell W, Curtis JR, Crow-Hercher R, White W, Ginsberg S, Clowse MEB.

Clin Rheumatol. 2019 Apr;38(4):1207-1212. doi: 10.1007/s10067-018-04420-1. Epub 2019 Jan 16.

PMID:
30649682
7.

Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks.

Clowse ME, Eudy AM, Revels J, Sanders GD, Criscione-Schreiber L.

Obstet Med. 2018 Dec;11(4):182-185. doi: 10.1177/1753495X18771266. Epub 2018 May 4.

PMID:
30574180
8.

Provider perceptions on the management of lupus during pregnancy: barriers to improved care.

Clowse MEB, Eudy AM, Revels J, Neil L, Sanders GD.

Lupus. 2019 Jan;28(1):86-93. doi: 10.1177/0961203318815594. Epub 2018 Dec 6.

PMID:
30522398
9.

Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis.

Eudy AM, McDaniel G, Hurd WW, Clowse MEB.

J Rheumatol. 2019 May;46(5):455-459. doi: 10.3899/jrheum.180176. Epub 2018 Nov 15.

PMID:
30442826
10.

A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus.

Pisetsky DS, Clowse MEB, Criscione-Schreiber LG, Rogers JL.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):735-741. doi: 10.1002/acr.23794. Epub 2019 Apr 23. Review. No abstract available.

PMID:
30354033
11.

Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.

Balevic SJ, Cohen-Wolkowiez M, Eudy AM, Green TP, Schanberg LE, Clowse MEB.

J Rheumatol. 2019 Jan;46(1):57-63. doi: 10.3899/jrheum.180158. Epub 2018 Oct 1.

PMID:
30275257
12.

Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases.

Balevic SJ, Green TP, Clowse MEB, Eudy AM, Schanberg LE, Cohen-Wolkowiez M.

Clin Pharmacokinet. 2019 Apr;58(4):525-533. doi: 10.1007/s40262-018-0712-z.

PMID:
30255310
13.

Power in numbers.

Vinet E, Chakravarty EF, Clowse MEB.

Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v40-v47. doi: 10.1093/rheumatology/key111.

14.

The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices.

Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E, Sammaritano LR, Chambers CD, Buyon J.

Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v9-v17. doi: 10.1093/rheumatology/key141.

15.

Contraception Use Among Reproductive-Age Women With Rheumatic Diseases.

Birru Talabi M, Clowse MEB, Blalock SJ, Moreland L, Siripong N, Borrero S.

Arthritis Care Res (Hoboken). 2019 Aug;71(8):1132-1140. doi: 10.1002/acr.23724. Epub 2019 Jul 3.

PMID:
30106516
16.

Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic.

Sadun RE, Wells MA, Balevic SJ, Lackey V, Aldridge EJ, Holdgagte N, Mohammad S, Criscione-Schreiber LG, Clowse MEB, Yanamadala M.

BMJ Open Qual. 2018 Jul 25;7(3):e000269. doi: 10.1136/bmjoq-2017-000269. eCollection 2018.

17.

Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, Petri M.

J Rheumatol. 2019 Jan;46(1):70-77. doi: 10.3899/jrheum.171066. Epub 2018 Jul 15.

PMID:
30008449
18.

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.

Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A, Zhang H, Graham D, Clowse MEB, Feldman SR, Baumgart DC.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2494-2500. doi: 10.1093/ibd/izy160.

19.

Response to: 'Postpartum breastfeeding status' by Betzold.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, Petri M.

Ann Rheum Dis. 2019 May;78(5):e38. doi: 10.1136/annrheumdis-2018-213427. Epub 2018 Apr 11. No abstract available.

PMID:
29643109
20.

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.

Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F.

Arthritis Rheumatol. 2018 Sep;70(9):1399-1407. doi: 10.1002/art.40508. Epub 2018 Jul 22.

21.

Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose.

Palmsten K, Rolland M, Hebert MF, Clowse MEB, Schatz M, Xu R, Chambers CD.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):430-438. doi: 10.1002/pds.4410. Epub 2018 Feb 28.

22.

Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, Petri M.

Ann Rheum Dis. 2018 Jun;77(6):855-860. doi: 10.1136/annrheumdis-2017-212535. Epub 2018 Feb 20.

23.

Pregnancy in rheumatoid arthritis: a retrospective study.

Eudy AM, McDaniel G, Clowse MEB.

Clin Rheumatol. 2018 Mar;37(3):789-794. doi: 10.1007/s10067-017-3939-4. Epub 2017 Dec 8. No abstract available.

PMID:
29222600
24.

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.

Clowse ME, Förger F, Hwang C, Thorp J, Dolhain RJ, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW.

Ann Rheum Dis. 2017 Nov;76(11):1890-1896. doi: 10.1136/annrheumdis-2017-211384. Epub 2017 Aug 16.

25.

Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus.

Eudy AM, Jayasundara M, Haroun T, Neil L, James AH, Clowse MEB.

Lupus. 2018 Mar;27(3):351-356. doi: 10.1177/0961203317720525. Epub 2017 Jul 12.

PMID:
28699378
26.

Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.

Mohammad S, Clowse MEB, Eudy AM, Criscione-Schreiber LG.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):481-485. doi: 10.1002/acr.23296. Epub 2018 Feb 9.

27.

Family Planning Counseling for Women With Rheumatic Diseases.

Birru Talabi M, Clowse MEB, Schwarz EB, Callegari LS, Moreland L, Borrero S.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):169-174. doi: 10.1002/acr.23267. Review. No abstract available.

28.

Vasculitis and Pregnancy.

Machen L, Clowse ME.

Rheum Dis Clin North Am. 2017 May;43(2):239-247. doi: 10.1016/j.rdc.2016.12.005. Epub 2017 Mar 15. Review.

PMID:
28390566
29.

Gestational weight gain in women with systemic lupus erythematosus.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse ME, Petri M.

Lupus. 2017 May;26(6):623-632. doi: 10.1177/0961203316671811. Epub 2016 Oct 4.

30.

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.

Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group.

Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856.

31.

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.

Clowse ME, Feldman SR, Isaacs JD, Kimball AB, Strand V, Warren RB, Xibillé D, Chen Y, Frazier D, Geier J, Proulx J, Marren A.

Drug Saf. 2016 Aug;39(8):755-62. doi: 10.1007/s40264-016-0431-z.

32.

Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain.

Duan-Porter W, Goldstein KM, McDuffie JR, Hughes JM, Clowse ME, Klap RS, Masilamani V, Allen LaPointe NM, Nagi A, Gierisch JM, Williams JW Jr.

Ann Intern Med. 2016 Aug 2;165(3):184-93. doi: 10.7326/M15-2877. Epub 2016 Apr 26.

33.

Breastfeeding in mothers with systemic lupus erythematosus.

Noviani M, Wasserman S, Clowse ME.

Lupus. 2016 Aug;25(9):973-9. doi: 10.1177/0961203316629555. Epub 2016 Feb 16.

PMID:
26888577
34.

Racial and Ethnic Disparities in the Pregnancies of Women With Systemic Lupus Erythematosus.

Clowse ME, Grotegut C.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1567-72. doi: 10.1002/acr.22847. Epub 2016 Aug 19.

35.

Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.

Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U.

J Rheumatol. 2015 Dec;42(12):2270-8. doi: 10.3899/jrheum.140189. Epub 2015 Nov 1.

36.

Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.

Wallace DJ, Hobbs K, Clowse ME, Petri M, Strand V, Pike M, Merrill JT, Leszczyński P, Neuwelt CM, Jeka S, Houssiau F, Keiserman M, Ordi-Ros J, Bongardt S, Kilgallen B, Galateanu C, Kalunian K, Furie R, Gordon C.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):534-43. doi: 10.1002/acr.22694.

37.

Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.

Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, Coca A, Chatham WW, Clowse ME, Criscione-Schreiber LG, Callahan S, Goldmuntz EA, Keyes-Elstein L, Oswald M, Gregersen PK, Diamond B.

Arthritis Rheumatol. 2015 Jul;67(7):1848-57. doi: 10.1002/art.39108.

38.

State of the art: Reproduction and pregnancy in rheumatic diseases.

Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M.

Autoimmun Rev. 2015 May;14(5):376-86. doi: 10.1016/j.autrev.2014.12.011. Epub 2014 Dec 30. Review.

PMID:
25555818
39.

Aspirin for prevention of preeclampsia in lupus pregnancy.

Schramm AM, Clowse ME.

Autoimmune Dis. 2014;2014:920467. doi: 10.1155/2014/920467. Epub 2014 Mar 20. Review.

40.

Fertility and infertility in rheumatoid arthritis.

Provost M, Eaton JL, Clowse ME.

Curr Opin Rheumatol. 2014 May;26(3):308-14. doi: 10.1097/BOR.0000000000000058. Review.

PMID:
24663108
41.

Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives.

Chakravarty E, Clowse ME, Pushparajah DS, Mertens S, Gordon C.

BMJ Open. 2014 Feb 5;4(2):e004081. doi: 10.1136/bmjopen-2013-004081.

42.

Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature.

Peart E, Clowse ME.

Curr Opin Rheumatol. 2014 Mar;26(2):118-23. doi: 10.1097/BOR.0000000000000030. Review.

PMID:
24419751
43.

Pregnancy outcomes among patients with vasculitis.

Clowse ME, Richeson RL, Pieper C, Merkel PA; Vasculitis Clinical Research Consortium.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1370-4. doi: 10.1002/acr.21983.

44.

Reply: To PMID 22505314.

Somers TJ, Kurakula PC, Criscione-Schreiber L, Keefe FJ, Clowse ME.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1205. doi: 10.1002/acr.21960. No abstract available.

45.

Predictors of preterm birth in patients with mild systemic lupus erythematosus.

Clowse ME, Wallace DJ, Weisman M, James A, Criscione-Schreiber LG, Pisetsky DS.

Ann Rheum Dis. 2013 Sep 1;72(9):1536-9. doi: 10.1136/annrheumdis-2012-202449. Epub 2013 Jan 29.

PMID:
23361085
46.

Depressive symptoms and associated factors in systemic lupus erythematosus.

Karol DE, Criscione-Schreiber LG, Lin M, Clowse ME.

Psychosomatics. 2013 Sep-Oct;54(5):443-50. doi: 10.1016/j.psym.2012.09.004. Epub 2012 Dec 27.

PMID:
23274009
47.

The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.

Harward LE, Mitchell K, Pieper C, Copland S, Criscione-Schreiber LG, Clowse ME.

Lupus. 2013 Jan;22(1):81-6. doi: 10.1177/0961203312468624.

PMID:
23263867
48.

Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents.

Tunks RD, Clowse ME, Miller SG, Brancazio LR, Barker PC.

Am J Obstet Gynecol. 2013 Jan;208(1):64.e1-7. doi: 10.1016/j.ajog.2012.09.020. Epub 2012 Sep 28.

PMID:
23063019
49.

Self-efficacy and pain catastrophizing in systemic lupus erythematosus: relationship to pain, stiffness, fatigue, and psychological distress.

Somers TJ, Kurakula PC, Criscione-Schreiber L, Keefe FJ, Clowse ME.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1334-40. doi: 10.1002/acr.21686.

50.

Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.

Clowse ME, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S.

Arthritis Rheum. 2012 May;64(5):1305-10. doi: 10.1002/art.34431. No abstract available.

Supplemental Content

Loading ...
Support Center